Professional Documents
Culture Documents
Dr. Khairul P. Surbakti, SP.S Departemen Neurologi FK USU/RSUP H. Adam Malik Medan
Dr. Khairul P. Surbakti, SP.S Departemen Neurologi FK USU/RSUP H. Adam Malik Medan
S
Departemen Neurologi
FK USU/RSUP H. Adam Malik Medan
1
headache disorder
Headache alarm
Differential
diagnosis
Possible work-up
Temporal arteritis,mass
lesion
ESR,Neuroimaging
Sudden-onset headache
SAH,AVM,mass lesion
Neuroimaging,LP
Accelerating pattern of
headache
Mass
lesion,SDH,Medication
overuse
Neuroimaging,drug
screen
New-onset headache in a
patient with cancer or HIV
Meningitis,brain
abscess,metastasis
Neuroimaging,LP
Meningitis,encephalitis,sy
stemic
infection,collagen,vascula
r disease
Neuroimaging,LP,blood
tests
Focal neurologic
symptoms or signs of
diseases (other than
typical aura)
Mass
lesion,AVM,stroke,collage
n,vascular diseases
Neuroimaging,collagen
vascular evaluation
Papilledema
Mass
lesion,pseudotumor,meni
ngitis
Neuroimaging,LP
5
Features
Migraine 10-40
Hemicra hours
nia
to 3 days
severe
phobia
Moderate ThrobNausea,vomit
bing
Photo/phono
Tension type
20-50
Bilateral 30 to 7
days moderate Bandlike none
Cluster 15-40
peri/retro
orbital
Mild to
Mass lesion
Any
rigidity,neurolo
gic deficits
Variable
Presslike Generally
Ipsilat conj inj,
Vomit,nuchal
Sub arachnoid
Hemorrhage
neuro deficit
Adult
Global, oc Variable
cipitonuchal
ting
Trigeminal
neuralgia
1st of N.V
50-70
More 2nd Seconds Excrucia- Electric Facial trigger
3rd div.than
ting
shock
point, spasm of
like
facial muscles
Giant cell
>55
arteritis any region
rheumatica
Variable
ous
Tender scalp
myalgia
in metabolic disorder:
- Hyponatremia
- Hypernatremia
- Acid base abnormalities
- Liver and kidney failure
head
ache is no longer a complain
1. Migraine
2. Tension Type headache
3. Cluster Headache and other trigeminal
autonomic cephalgias
4. Other Primary Headaches
II. The secondary Headaches
5. Headache attributed to head or/and
neck
trauma
10
6. Headache attributed
vascular disorder
7. Headache attributed
intrcranial disorder
8. Headache attributed
its
withdrawal
9. Headache attributed
to cranial or cevical
to non vascular
to a substance or
to infections
11
12
Associated symptoms
(Any 1)
Unilateral
Pulsatile quality
Moderate to severe
intensity
Aggravated by routine
physical activity
Tension
Headache description
(Any 2)
Associated symptoms
(Any 1)
Unilateral
Pulsatile quality
Moderate to severe
intensity
Aggravated by routine
physical activity
Must have had no previous headache episodes and no
evidence of secondary headache
15
Autonomic Symptoms
( Any 2 )
. Severe headache
. Unilateral
. Duration of 15 180 min
. Orbital, periorbital or
temporal location
.
.
.
.
.
.
.
Rhinorrhoea
Lacrimation
Facial sweating
Miosis
Eyelid edema
Conjuctival injection
Ptosis
16
History
The following areas of historical
information should be explored:
1.Chronicity
2.Age at onset
3.Duration and frequency of pain
4.Onset to peak time
5.Location
6.Character and severity of pain
7.Premonitory symptoms and aura
17
symptoms
- Visual : (+) flickering light, spots
or
lines
(-) loss of vision
Sensory : (+) pins & needles
(-) numbness
Speech : dysphasic disorder
18
8. Associated symptoms
9. Precipitating factors
10. Environmental factors
11. Family history
12. Pregnancy and menstruation
13. Medical/surgical history
14. Past Treatments
15. Previous diagnostic tests
19
Physical Examination
1.General Appearance
2.Examination of the head
3.Cervical spine
4.Cranial nerve evaluation
5.Sensory examination
6.Motor Examination
7.Reflexes
20
Laboratory Testing
Laboratory testing is generally
ordered to rule out unsuspected
systemic illness in which headache
or facial pain may be featured :
Anemia
Infection
Diabetes
21
Radiographic Testing
Plain skull radiograph can provide
22
cervicogenic headache
23
Lumbar Puncture :
- Infectious causes
- Subarachnoid hemorrhage
LP should not be performed in the
presence
of increased ICP evidenced by
papilledema on funduscopic examination
or finding on CT or MRI scanning
24
Angiography :
aneurysms
angiomas
AVM
Vascular tumors responsible
for
their headache and facial
pain
25
TREATMENT
I. Migraine
1. Avoid precipitating/triggering factors
Identify these by keeping a diary if
necessary
2. Treatment of acute migraine attack
A. Ancillary measures
. Rest in a quiet dark room
. IVFD if severely dehydrated
B. Non soecific analgesics and antiemetic
26
27
Dose, mg
Level of
recommendati
on
Comment
ASA
1000 (oral)
ASA
1000 (i.v)
Risk of bleeding
Ibuprofen
200-800
Naproxen
500-1000
Diclofenac
50-100
Including diclof-K
Paracetamol
1000 (0ral)
10009 (supp.)
ASA plus
250 (oral)
Mol plus
Caffein
200-250
50
Metamizol
1000 (oral)
Risk of
agranulocytosis
1000 (i.v)
Risk of hypotension
Phenazon
1000 (oral)
See Paracetamol
Tolfenamic acid
200 (oral)
Triptans
Substance
Dose, mg
Level Comment
Sumatriptan
Zolmitriptan
2.5, 5 (oral
including
desintegrating
form)
2.5, 5 (Nasal
spray)
Naratriptan
2.5 (oral)
Rizatriptan
10 (oral)
Almotriptan
12.5 (oral)
100 mg sumatriptan is
reference to all triptans
29
Dose, mg
Level
Comment
Metoclopramid
e
10-20 (oral)
20
(suppository)
10 (i.m; i.v,
sc )
Side effect:
dyskinesia,
contraindicate
d in childhood
and in
pregnancy;
also analgesic
efficacy
Domperidon
20-30 (oral)
Side effects
less severe
than in
metoclopramid
e; can be given
to children
30
Level of
recommendation
50-200
40-240
A
A
A
5-10
500-1800
25-100
A
A
31
Level of
recommendation
Amitriptyline
50-150
Venlafaxine
75-150
Naproxene
2 x 250-500
Bisoprolol
5-10
32
Daily dose
Level of
recommendation
ASA
300 mg
Gabapentin
1200-1600 mg
Magnesium
24 mmol
Riboflavin
400 mg
Coenzyme Q10
300 mg
Candesartan
16 mg
Lisinopril
20 mg
Methysergide
4-12 mg
33
34
4. Antidepressant
- Amitiptyline 10- 150 mg
- Antianxiety : Benzodiazepine
1. Dietary control
2. Avoid of precipitating factors
3. Avoid of consuming daily analgesics, sedative and
ergotamine
4. Behavioral Therapy : Stress management therapy,
Conseling, Relaxation therapy, cognitive
behavioral
therapy
35
36
37
38